| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Nu-Med Plus, Inc.
13D
NUMD · 67021R104
|
9.7% |
8/25/2026
Event 7/8/2026
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.